Antibiotics-Cell Wall Agents Flashcards
1
Q
Penicillin G
A
- Penicillins – usually IM, can be IV
- Acid-labile (broken down in stomach) – inhibit PBPs and PDG cross-linking - bactericidal
- Allergies, dose dependent neurotoxicity and seizures, Stevens Johnson syndrome
- Gram + and some gram – cocci (Strep pneumonia, Staph, Neisseria, Clostridium, Treponema pallidum)
2
Q
Penicillin V
A
- Penicillins - oral
- Acid stable – inhibit PBPs and PBG cross-linking - bactericidal
- Allergies, Stevens Johnson syndrome
- Gram + and some gram – cocci (Strep pneumonia, Staph, Neisseria, Clostridium, Treponema pallidum)
3
Q
Oxacillin
Nafcillin
A
*B-lactamase resistant
Penicillinase-resistant
*Acid stable, food interferes with absorption, give parenterally - inhibit PBPs and PBG cross-linking - bactericidal
*Hepatitis at high doses
*Penicillinase-producing Staph and Strep (NOT FOR MRSA)
4
Q
Amoxicillin
Ampicillin
A
- Extended spectrum
- Destroyed by B-lactamases – acid stable, amoxicillin > ampicillin absorption - inhibit PBPs and PBG cross-linking - bactericidal
- Non-lactamase gram- bacilli (E. coli, H. influenza, Salmonella, Shigella), prophylaxis against bacterial endocarditis
5
Q
Piperacillin
A
- Extended spectrum – parenteral administration
- Destroyed by B-lactamases - inhibit PBPs and PBG cross-linking - bactericidal
- Serious systemic infections (Klebsiella and Pseudomonas) – combo with aminoglycoside to prevent resistance
6
Q
Ticarcillin
A
- Extended spectrum – parenteral administration
- Destroyed by B-lactamases - inhibit PBPs and PBG cross-linking - bactericidal
- Anti-pseudomonal, rarely used alone
7
Q
Clavulanic acid
Sulbactam
Tazobactam
A
- B-lactamase inhibitor
- B-lactamase suicide inhibitors
- Used in fixed concentrations with extended spectrum penicillins
8
Q
Cefazolin
A
- Cephalosporin – 1st generation – oral, IV, IM
- Bind to PBPs and inhibit cell wall synthesis – best acid stability
- Allergy
- Broadest spectrum against gram + cocci (surgical prophylaxis), gram – bacilli
9
Q
Cefuorxime
A
- Cephalosporin – 2nd generation – oral, IV, IM
- Bind to PBPs and inhibit cell wall synthesis
- Allergy, Antabuse effect (sensitivity to alcohol)
- Activity against anaerobes – diverticulitis, sinusitis, peritonitis, otitis media
10
Q
Cefotaxime
A
- Cephalosporin – 3rd generation – oral, IV, IM
- Bind to PBPs and inhibit cell wall synthesis
- Allergy, Antabuse effect (sensitivity to alcohol)
- Anti-pseudomonal and pneumococcal, serious gram – infections (meningitis, pneumonia, gonorrhea) – children and infants
11
Q
Cefepime
A
- Cephalosporin – 4th generation – oral, IV, IM
- Bind to PBPs and inhibit cell wall synthesis
- Allergy
- Anti-pseudomonal, high resistance to B-lactamases (good for Enterobacter and penicillin resistant Strep)
12
Q
Imipenem
A
- Carbapenem – parenteral administration
- Has B-lactam ring, binds more efficiently with PBPs, penetrate outer membrane of gram - bacteria
- GI effects, super infections, neurtoxicity - Renal metabolism and inactivation (administered with cilastatin – inhibits dehydropeptidases)
- Broadest activity of all B-lactam drugs, NOT for MRSA or VRE – 2nd line for serious nosocomial infections
13
Q
Aztreonam
A
- Monobactam – IM or IV use
- Binds PBPs, relatively resistant to B-lactamases – drug penetrates inflamed CNS
- No significant cross-reactivity with
- Narrow spectrum, limited to gram- aerobes (Pseudomonas), not gram + or anaerobes – use for gram – UTIs, lower RTIs, and systemic infections
14
Q
Bacitracin
A
- Peptidoglycan synthesis inhibitor
- Depletes lipid carrier for PDG synthesis – poorly absorbed
- Severe nephrotoxicity
- Topical only! – Narrow spectrum (gram +, Neisseria, T. pallidum) – skin and ophthalmologic infections (combination with polymyxin B)
15
Q
Cycloserine
A
- Peptidoglycan synthesis inhibitor
- Structural analog of D-alanine, blocks step 2 – good CNS penetration
- VERY TOXIC – serious CNS effects, dose related, reversible
- Broad spectrum – restricted second-line M. tuberculosis
16
Q
Daptomycin
A
- Cell membrane agent – IV administration
- Membrane depolarization, bactericidal
- Myopathy
- Narrow spectrum –serious gram+ infections, penicillin resistant S. pneumonia, VRE and MRSA
17
Q
Fosfomycin
A
- Peptidoglycan synthesis inhibitor
- Structural analog of PEP, blocks step 1 – well absorbed and distributed, rapid resistance
- Few adverse effects (diarrhea, vaginitis)
- Broad spectrum – single dose oral treatment of uncomplicated UTIs (E. coli and E. faecalis)
18
Q
Vancomycin
A
- Peptidoglycan synthesis inhibitor – IV administration (SLOW), rarely oral (poor absorption, excellent distribution
- Inhibits growth of strand by binding to D-ala dimer – blocks cross-linking by binding substrate – rapidly bactericidal for dividing cultures (except static in enterococci)
- too fast IV administration – histamine release – HTN, tachycardia, flushing), ototoxicity, nephrotoxicity
VRE and VRSA resitant
*Narrow spectrum – gram + microbes (DRUG OF CHOICE FOR MRSA) – serious gram+ infections, penicillin resistant S. pneumonia, combination with aminoglycosides (synergistic)